Libros importados con hasta 50% OFF + Envío Gratis a todo USA  Ver más

menu

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
portada Pharma and Profits: Balancing Innovation, Medicine, and Drug Prices (in English)
Type
Physical Book
Publisher
Language
Inglés
Pages
112
Format
Paperback
Dimensions
22.1 x 14.7 x 1.0 cm
Weight
0.14 kg.
ISBN13
9781119881339
Edition No.
1

Pharma and Profits: Balancing Innovation, Medicine, and Drug Prices (in English)

John L. Lamattina (Author) · Wiley · Paperback

Pharma and Profits: Balancing Innovation, Medicine, and Drug Prices (in English) - Lamattina, John L.

New Book

$ 23.96

$ 29.95

You save: $ 5.99

20% discount
  • Condition: New
It will be shipped from our warehouse between Monday, June 24 and Tuesday, June 25.
You will receive it anywhere in United States between 1 and 3 business days after shipment.

Synopsis "Pharma and Profits: Balancing Innovation, Medicine, and Drug Prices (in English)"

High-level commentary on various facets of the pharmaceutical industry from a key leader in the field This book clearly explains the value that the pharmaceutical industry offers to society which is often underreported against the more negative topic of high drug prices. It also offers an overview for drug discovery and development professionals, highlighting the challenges that such drug hunters should be aware of when developing new drugs. Case studies to illustrate topics like hepatitis C, mRNA vaccines, insulin, and price controls are included to aid in seamless reader comprehension. Written by John LaMattina, former president of Pfizer Global Research and Development and well-known speaker and writer for the pharma industry, sample topics covered and questions explored within the work include: Fiscal consequences of curing hepatitis C mRNA vaccines and the race for a cure Why the government does not deserve a piece of Biopharma's profits Paying for drugs whose ultimate value is unknown The impact of reduced revenues on R&DThis book is a must-read for biopharmaceutical professionals and executives who wish to gain high-level insight into key challenges that must be first understood, then overcome, within the pharmaceutical industry.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews